More Related Content
More from Shabab Ali (20)
Ch16 (3)
- 1. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis CompanyCopyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Chapter Sixteen
- 2. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Figure 16-1
- 3. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Because the components of the humoral and
cell-mediated portions of the immune system
interact extensively through many regulatory
and effector loops, a defect in one arm of the
system may affect other aspects of immune
function as well.
With the exception of IgA deficiency,
primary immunodeficiency syndromes are
rare.
- 4. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
A deficiency of one component of the system is
often accompanied by hyperactivity of other
component, including allergic or autoimmune
manifestations.
More than 120 different congenital forms of
immunodeficiency have been reported, including
defects in lymphoid cells, phagocytic cells, and
complement proteins. Some are X-linked; some
are autosomal recessive. When NK cells are
reduced, there is a higher rate of malignancy.
- 5. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
The clinical symptoms associated with immune
deficiencies range from very mild or subclinical to
severe recurrent infections or failure to thrive.
In general, defects in humoral immunity result in
pyogenic bacterial infections, particularly of the
upper and lower respiratory tract.
Complement deficiencies result in recurrent
bacterial infections and autoimmune problems.
- 6. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Defects in T-cell-mediated immunity result in
recurrent infections with intracellular
pathogens such as viruses, fungi, and
intracellular bacteria.
These patients are also prone to
disseminated viral infections, especially with
latent viruses such as herpes simplex,
varicella zoster, and cytomegalovirus.
- 7. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
The mechanisms of the agammaglobulinemias
include genetic defects in B-cell maturation or
mutations leading to defective interactions
between B and T cells.
Only the more common and well-characterized
syndromes are described here and are
summarized in Table 16-1.
- 8. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
In evaluating immunoglobulin deficiency
states, it is important to remember that blood
levels of immunoglobulins change with
age.
IgM reaches normal adult levels first, around 1
year of age, followed by IgG at about 5 to 6
years of age.
In some normal children, IgA levels do not
reach normal adult values until adolescence.
- 9. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – THI
All infants experience low levels of
immunoglobulins at approximately 5 to 6
months of age, but in some cases, the low
levels persist for a longer time.
Transient hypogammaglobulinemia of
infancy may result.
The mechanism of this transient
hypogammaglobulinemia is not known.
- 10. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
Bruton’s agammaglobulinemia, first
described in 1952, is X chromosome–linked,
and so affects males almost exclusively.
Patients with X-linked agammaglobulinemia
lack circulating mature CD19 positive B cells
and exhibit a deficiency or lack of
immunoglobulins of all classes.
- 11. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
Patients have no plasma cells in their
lymphoid tissues, but they do have pre-B cells
in their bone marrow.
T cells are normal in number and function.
These patients develop recurrent bacterial
infections beginning in infancy, as maternal
antibody is cleared.
- 12. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
X-linked hypogammaglobulinemia results from
arrested differentiation at the pre-B cell stage,
leading to a complete absence of mature B
cells and plasma cells.
The underlying genetic mechanism is a
deficiency of an enzyme called the Bruton
tyrosine kinase (Btk) in B-cell progenitor cells.
- 13. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
Lack of the Btk enzyme apparently causes a
failure of Vh gene rearrangement.
The syndrome can be differentiated from
transient hypogammaglobulinemia of infancy
by the absence of CD19 positive B cells in the
peripheral blood, by the abnormal histology of
lymphoid tissues, and by its persistence
beyond 2 years of age.
- 14. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – IgA Def
Most patients with IgA deficiency are
asymptomatic. This is the most common
congenital immune deficiency and appears to
be a failure in isotype switching in B cells.
Those patients with symptoms usually have
infections of the respiratory and
gastrointestinal tract and an increased
tendency to autoimmune diseases and
allergies
- 15. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CVI
Common variable immunodeficiency (CVI)
is a heterogeneous group of disorders ,
leading to IgG and IgA deficiencies
The disorder can be congenital or acquired,
familial or sporadic, and it occurs with equal
frequency in men and women.
leads to recurrent bacterial infections,
particularly sinusitis and pneumonia.
- 16. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CVI
In contrast to X-linked agammaglobulinemia,
most patients with CVI have normal numbers
of mature B cells, but they fail to transform into
plasma cells.
- 17. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Defects in cell-mediated immunity can
result from abnormalities at many different
stages of T-cell development.
In some cases, a primary defect in cell-
mediated immunity can also have secondary
effects on humoral immunity.
- 18. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – DGA
The immunodeficiency associated with the
DiGeorge anomaly is a quantitative defect in
thymocytes due to a developmental defect in
the thymus.
Insufficient mature T cells are made, but those
that are present are functionally normal. May
undergo bone marrow or thymus transplant.
- 19. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Defects in both humoral (B cell) and cell-
mediated (T cell) immunity can be caused
by a defect that affects development of both
types of lymphocytes or a defective interaction
between the two limbs of the immune system.
- 20. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – SCID
The most serious of the congenital immune
deficiencies is severe combined
immunodeficiency (SCID).
SCID is actually a group of related diseases
that all affect T- and B-cell function but with
differing causes.
X-linked SCID is the most common form of the
disease, presenting in early infancy with
multiple types of infections.
- 21. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – SCID
The abnormal gene involved codes for a
protein chain called the common gamma
chain, which is common to receptors for
interleukins 2, 4, 7, 9, 15, and 21.
The gene is referred to as the IL2RG gene
and is located on the X chromosome.
Normal signaling cannot occur in cells with
defective receptors, thus halting proliferation
and maturation.
- 22. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Chronic granulomatous disease (CGD) is a
group of disorders inherited as either an X-
linked or autosomal recessive gene that
affects neutrophil microbicidal function.
X-linked disease accounts for 70 percent of
the cases, and it tends to be more severe.
CGD is the most common and best
characterized of the neutrophil
abnormalities.
- 23. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
There are three different autosomal recessive
genes involved, and all of these affect subunits
of nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase.
Normally, neutrophil stimulation leads to the
production of reactive oxygen molecules, such
as hydrogen peroxide (H2O2), by NADPH
oxidase on the plasma membrane.
- 24. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
Neutrophil granules fuse with, and release
their contents into, the forming phagosome, as
organisms are phagocytized.
Hydrogen peroxide is then used by the granule
enzyme myeloperoxidase to generate the
potent microbicidal agent hypochlorous acid.
In CGD, neutrophils are unable to undergo the
oxidative burst.
- 25. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
CGD was historically diagnosed by measuring
the ability of a patient’s neutrophils to reduce
the dye nitro-blue tetrazolium (NBT).
More recently, a flow cytometric assay has
become available.
Patients have a deficiency in G6PD for
hydrogen peroxide production, or
myeloperoxidase activity for hypochlorite
production
- 26. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – NGDD
Even if microbicidal activity is normal,
neutrophils cannot perform their functions
properly if they fail to leave the vasculature
and migrate to a site of incipient infection.
Adhesion receptors on leukocytes (integrins)
and their counter-receptors on endothelial
cells (selectins) and extracellular matrix play
important roles in these activities.
- 27. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
In leukocyte adhesion deficiency (LAD), a
protein (CD18) that is a component of
adhesion receptors on neutrophils and
monocytes (with CD11b or CD11c) and on T
cells (with CD11a) is defective.
This defect leads to abnormal adhesion,
motility, aggregation, chemotaxis, and
endocytosis by the affected leukocytes.
- 28. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – LAD
The defects are clinically manifested as
delayed wound healing, chronic skin
infections, intestinal and respiratory tract
infections, and periodontitis.
A defect in CD18 can be diagnosed by
detecting a decreased amount of the CD11/18
antigen on patient leukocytes by flow
cytometry.
- 29. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Deficiencies in each of the major
complement components have been
described, leading to various clinical
sequelae.
Deficiencies in the early complement
components, C1q, 4, and 2, are usually
associated with a lupus-like syndrome.
Deficiency of C2 is believed to be the most
common complement component deficiency.
- 30. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
A C3 deficiency may also have a lupus-like
clinical presentation but is more likely to
involve recurrent encapsulated organism
infection.
Deficiencies of the later components of
complement (C5–C9) are often associated
with recurrent Neisseria meningitidis
infections.
- 31. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Screening tests used for the initial
evaluation of suspected immunodeficiency
states are summarized in Table 16-3.
Measurement of the levels of serum IgG, IgM,
and IgA and levels of the subclasses of IgG
are used to screen for defects in antibody
production.
- 32. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
An overall assessment of antibody-mediated
immunity can be made by measuring antibody
responses to antigens to which the population
is exposed normally or following vaccination.
Delayed-hypersensitivity-type skin reactions
can be used to screen for defects in cell-
mediated immunity.
- 33. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Screening for complement deficiencies
usually begins with a CH50 assay to
determine the level of functional complement
in an individual.
See Chapter 6 for details of the CH50 assay.
Defects in neutrophil oxidative burst
activity may be detected by a flow cytometric
assay, as mentioned earlier.
- 34. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
If the screening tests detect an abnormality
or if the clinical suspicion is high, more
specialized testing will probably be
necessary to precisely identify an immune
abnormality.
Some of the tests used for confirming an
immunodeficiency state are summarized in
Table 16-4.
- 35. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Enumeration of classes of lymphocytes in the
peripheral blood, bone marrow, and lymph
nodes is performed by flow cytometry.
For example, an absence or profound
decrease in the number of CD3 positive cells
would be consistent with DiGeorge syndrome.
An absence of CD19 positive B cells suggests
Bruton’s agammaglobulinemia.
- 36. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Genetic testing is available for many
conditions, including the DiGeorge deletion,
the Wiskott-Aldrich gene, and the IL2RG
mutations in SCID.
T-cell function can be measured by
assessing the ability of isolated T cells to
proliferate in response to an antigenic stimulus
or to nonspecific mitogens in culture.
- 37. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Quantitative measurement of serum or
urine immunoglobulins by protein
electrophoresis is used in the workup of both
immunodeficiency states and some
lymphoproliferative disorders.
Protein electrophoresis allows reproducible
separation of the major plasma proteins (see
Chapter 4 for details).
- 38. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Additional evaluation of serum immunoglobulin
is performed if the SPE shows a monoclonal
component or if there is a significant
quantitative abnormality of serum
immunoglobulins.
Another method of characterizing immune
deficiencies is immunofixation
electrophoresis (IFE).
- 39. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Polyclonal immunoglobulins are indicated by
areas of diffuse staining, while monoclonal
bands produce narrow, intensely stained
bands.
Lack of bands indicates immunodeficiencies of
one or more immunoglobulin classes.
Refer to Figure 15-2 in Chapter 15 for
details regarding immunofixation.
See Figure 16-2 for further examples of IF.
- 40. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Figure 16-2
- 41. Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Specific immunoglobulin isotype levels
can be determined by nephelometry.
A bone marrow aspirate and biopsy is
indicated in any evaluation of monoclonal
gammopathy or immunodeficiency state.